Status:
COMPLETED
Cocaine Abuse and Attention Deficit Disorder - 3
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Collaborating Sponsors:
New York State Psychiatric Institute
Conditions:
Cocaine-Related Disorders
Eligibility:
All Genders
18-55 years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate cocaine abuse and Attention Deficit Disorder
Detailed Description
To evaluate the safety and efficacy of methylphenidate and bupropion in treating individuals with adult Attention Deficit Disorder.
Eligibility Criteria
Inclusion Criteria:
current adult ADHD current cocaine dependence
Exclusion Criteria:
no current major depression
Key Trial Info
Start Date :
May 1 1995
Trial Type :
INTERVENTIONAL
End Date :
November 1 1998
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT00000268
Start Date
May 1 1995
End Date
November 1 1998
Last Update
January 12 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
New York State Psychiatric Institute
New York, New York, United States, 10032